Akums Drugs and Pharmaceuticals Limited is all set to hit the stock market with its Initial Public Offering (IPO). The company has announced that the price band for its IPO has been fixed at ₹646 to ₹679 per share. This means that investors can bid for the shares within this price range.
The total value of the Akums Drugs IPO is ₹1,856.74 crores. Out of this, ₹680 crores will be fresh money raised by the company, while the remaining ₹1,176.74 crores will come from existing shareholders selling their shares.
The IPO will open for subscription on July 30, 2024, and will close on August 1, 2024. The allotment of shares is expected to be finalized on August 2, 2024, and the shares are likely to start trading on the stock exchange (BSE and NSE) from August 6, 2024.
Key Highlights of the IPO
- Price Band: ₹646 to ₹679 per share
- Total Issue Size: ₹1,856.74 crores
- Fresh Issue: ₹680 crores
- Offer for Sale (OFS): ₹1,176.74 crores
- IPO Open Date: July 30, 2024
- IPO Close Date: August 1, 2024
- Allotment Date: August 2, 2024
- Listing Date: August 6, 2024
Akums Drugs is a pharmaceutical company that makes medicines. They have a wide range of products, including tablets, capsules, ointments, and liquids. The company sells its products both in India and in other countries.
If you are interested in investing in Akums Drugs, you can start by checking the details of the IPO and understanding the company’s business. You can also seek guidance from a financial advisor for expert insights. Remember, investing in shares involves risks, and the value of shares can go up or down.
